Petros Pharmaceuticals Inc Ordinary Shares PTPI
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.00–0.03
- Bid/Ask
- $0.01 / $0.01
- Shares Outstanding
- 42.37M
- Market Cap
- $264,826.63
- Volume/Avg
- 39,835 / 116,497
Key Statistics
- Price/Earnings (Normalized)
- 0.02
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. The Company is working towards the goal of becoming an innovator in the emerging self-care market, driving expanded access to key nonprescription pharmaceuticals as Over-the-Counter and nonprescription drug products with additional conditions for nonprescription use (ACNU Products) treatment options. Petros is pursuing the development of a proprietary integrated technology solutions platform containing two components: SaaS, designed to assist pharmaceutical companies in operationalizing and commercializing an Rx-to-OTC switch as an element in the development of an ACNU Product, and a potential Software as a Medical Device component, which guides the consumer in navigating appropriate self-selection or deselection.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 3
- Website
- https://www.petrospharma.com
Valuation
|
Metric
|
PTPI
|
|---|---|
Price/Earnings (Normalized) | 0.02 |
Price/Book Value | 0.38 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
PTPI
Financial Strength
|
Metric
|
PTPI
|
|---|---|
Quick Ratio | 1.23 |
Current Ratio | 1.25 |
Interest Coverage | — |
Quick Ratio
PTPI
Profitability
|
Metric
|
PTPI
|
|---|---|
Return on Assets (Normalized) | 142.75% |
Return on Equity (Normalized) | 288.95% |
Return on Invested Capital (Normalized) | 281.64% |
Return on Assets
PTPI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|#hM^!?&s | LOCK|zgy<b | $68B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|pz@&$n#^ | LOCK|yc@V | $42B | |||
| Haleon PLC ADR
HLN
| LOCK|VQ^q?!n | LOCK|n$ | $40B | |||
| Zoetis Inc Class A
ZTS
| LOCK|t?>vZq!% | LOCK|tQG | $30B | |||
| Viatris Inc
VTRS
| LOCK|nskvZh | LOCK|$? | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|!c | LOCK|@p | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|qz$Yjv | LOCK|tV | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|X!v#@HP | LOCK|jF | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|?@H@qT# | LOCK|fYxY | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|@gJC^rk | LOCK|T>& | $2B |
United States